P004 – Longitudinal change in CT derived bone mineral density (BMD) in men with M0 prostate cancer treated with androgen receptor pathway inhibitors (ARPI): A sub-analysis of the STAMPEDE trial - Gray, S.; Connock, E.; D., McSweeney; Jones, C.; Brown, M.; Li, X.; E., DallAra; Brown, L.; Attard, G.; James, N.; Clark, N.; Sachdeva, A. (European urology, 2025)